Forecasting Hepatitis C liver disease burden on real‐life data. Does the <i>hidden iceberg</i> matter to reach the elimination goals?
Loreta A. Kondili(Istituto Superiore di Sanità), Sarah Robbins Scott(Center for Disease Analysis), Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Marco Massari(Azienda Sanitaria Unità Locale di Reggio Emilia), Angelo Andriulli(Casa Sollievo della Sofferenza), Guglielmo Borgia(University of Naples Federico II), Luchino Chessa(University of Cagliari), Francesco Paolo Russo(University of Padua), Pierluigi Blanc, Anna Linda Zignego(University of Florence), Antonio Gasbarrini(Università Cattolica del Sacro Cuore), Ivane Gamkrelidze, Mario Melazzini(Istituti Clinici Scientifici Maugeri), Mario Strazzabosco(Smilow Cancer Hospital), Salvatore Madonia(Ospedale Vincenzo Cervello), Andrea Iannone(University of Bari Aldo Moro), Marcello Persico(University of Salerno), Simona Montilla(Italian Medicines Agency), M. Vinci(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Gloria Taliani(Sapienza University of Rome), Andrea Gori(University of Milan), Giovanni Raimondo(University of Messina), Homie Razavi(Center for Disease Analysis), N. Caporaso(Federico II University Hospital), Alessia Ciancio(Department of Medical Sciences), Sarah Blach(Center for Disease Analysis), Pietro Andreoné, Stefano Vella, Maurizia Rossana Brunetto(University of Pisa), Massimo Zuin(AOL (United States)), Teresa Santantonio(Ospedali Riuniti di Foggia), Elke Erne(University of Padua), Donatella Ieluzzi(University of Verona), Maria Grazia Rumi(University of Milan), Antonio Craxı̀(University of Palermo), Alessandro Federico(University of Campania "Luigi Vanvitelli"), Giuseppina Brancaccio, Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), A. Orlandini(University of Parma), Maria Giovanna Quaranta(Istituto Superiore di Sanità), Carmine Coppola
Cited by 45
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k